首页> 外国专利> METHOD FOR PREDICTION OF EARLY PROGRESSING DIABETIC RETINOPATHY FOLLOWING ULTRASOUND PHACOEMULSIFICATION IN PATIENTS WITH DIABETES MELLITUS

METHOD FOR PREDICTION OF EARLY PROGRESSING DIABETIC RETINOPATHY FOLLOWING ULTRASOUND PHACOEMULSIFICATION IN PATIENTS WITH DIABETES MELLITUS

机译:在糖尿病患者中进行超声超塑化后的早期糖尿病视网膜病变的预测方法

摘要

FIELD: medicine.;SUBSTANCE: pre- and post-operative, 3-5-day and 10-th day postoperative lachrymal fluid is examined for proangiogenic vascular endothelial growth factor (VEGF), pcg/ml and antiangiogenic pigment epithelium-derived factor (PEDF), g/ml. It is followed by determining indices of a risk of progression (IRP) of diabetic retinopathy by the relation of the postoperative values of each factors to the preoperative values. And if each IRP VEGF exceeds 1.2, while each IRP PEDF is less than 0.2, progressing diabetic retinopathy is predicted.;EFFECT: improved quality of management, and respectively adequate treatment prescribed of the patient with diabetic retinopathy following minimally invasive phacoemulsification with IOL implantation with an incision less than 2,2 mm.;3 ex
机译:领域:医学;研究对象:术前和术后,术后3-5天和10天的泪液,检查促血管生成血管内皮生长因子(VEGF),pcg / ml和抗血管生成色素上皮衍生因子( PEDF),克/毫升。然后通过各因素的术后值与术前值之间的关系来确定糖尿病性视网膜病变进展风险(IRP)的指标。并且,如果每个IRP VEGF均超过1.2,而每个IRP PEDF均小于0.2,则可预示糖尿病性视网膜病变的进展。小于2.2毫米的切口; 3 ex

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号